Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yaz for PMDD in Bipolar Disorder
NCT05098574Phase 2Completed
- Sponsor
- St. Joseph's Healthcare Hamilton
- Start
- Feb 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ethinyl estradiol + drospirenone in Premenstrual Dysphoric Disorder (PMDD), sponsored by St. Joseph's Healthcare Hamilton. Started Feb 2023; status: completed.
02
Drugs
ethinyl estradiol + drospirenone
03
Conditions
Premenstrual Dysphoric Disorder (PMDD)
Beyond the preview
Go deeper on NCT05098574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05098574.